An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
ANI Pharmaceuticals to Present at the Piper Sandler 33rd Annual Healthcare Conference 2021
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
ANI Pharmaceuticals will present at the Piper Sandler 33rd Annual Healthcare Conference on November 22, 2021, at 10:00 a.m. ET. CEO Nikhil Lalwani and CFO Stephen Carey will lead the presentation, which will also involve 1x1 meetings by request via Piper Sandler. The webcast will be available on demand for 90 days on the company's website. ANI is a diversified bio-pharmaceutical company focused on developing high-quality branded and generic prescription products for patients with unmet medical needs.
Positive
None.
Negative
None.
BAUDETTE, Minn.--(BUSINESS WIRE)--
ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present virtually at the Piper Sandler 33rd Annual Healthcare Conference 2021 as follows:
The webcast will be accessible on demand and archived for 90 days thereafter, via the Company’s website at www.anipharmaceuticals.com, under the Investors section.
ANI Pharmaceuticals will be participating in 1x1 meetings. Meetings can be requested exclusively via Piper Sandler.
About ANI
ANI Pharmaceuticals is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. For more information, please visit www.anipharmaceuticals.com.
Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc. T: 212-452-2793
E: lwilson@insitecony.com
Source: ANI Pharmaceuticals, Inc.
FAQ
When will ANI Pharmaceuticals present at the Piper Sandler Healthcare Conference?
ANI Pharmaceuticals will present on November 22, 2021, at 10:00 a.m. ET.
Who will represent ANI Pharmaceuticals at the conference?
Nikhil Lalwani, CEO, and Stephen Carey, CFO, will represent ANI Pharmaceuticals.
How can I access the ANI Pharmaceuticals conference webcast?
The webcast will be available on demand for 90 days on ANI's website.
What is the focus of ANI Pharmaceuticals as a company?
ANI Pharmaceuticals focuses on developing, manufacturing, and marketing branded and generic prescription products, particularly for unmet medical needs.
Are there any 1x1 meetings available during the conference?
Yes, ANI Pharmaceuticals will participate in 1x1 meetings, which can be requested exclusively via Piper Sandler.
